论文部分内容阅读
目的探讨肾癌保留肾单位手术的临床价值和疗效。方法回顾性分析10例行保留肾单位手术的肾癌患者临床资料,其中单侧9例、双侧1例。绝对指征1例,相对指征3例,选择性指征6例。肿瘤直径1.8-4.5cm,均为T1期(1997年TNM标准);行改良肾肿瘤剜除术(切缘于肾肿瘤外1cm正常肾实质处)7例,肾上极切除术1例,肾下极切除术2例。结果10例患者随访4-60个月,平均30个月,未见并发症及残肾肿瘤复发,无瘤生存率与根治性手术者相近。结论肾癌保留肾单位手术安全、有效,适合于对侧肾功能正常、一侧局限且较小的肾肿瘤患者。
Objective To investigate the clinical value and curative effect of nephron preserving nephron surgery. Methods The clinical data of 10 patients with renal cell carcinoma who retained nephron surgery were retrospectively analyzed, including 9 cases of unilateral and 1 case of bilateral. Absolute indications in 1 case, relative indications in 3 cases, selective indications in 6 cases. Tumor diameter 1.8-4.5cm, are T1 (1997 TNM standard); line improved nephrectomy (1cm away from the renal tumor outside the normal renal parenchyma) in 7 cases, 1 case of suprarenal excision, kidney Subtotal excision in 2 cases. Results 10 patients were followed up for 4-60 months, an average of 30 months, no complications and residual renal tumor recurrence, tumor-free survival rate and radical surgery were similar. Conclusion The nephron preserving nephron surgery is safe and effective. It is suitable for patients with renal tumors that have normal renal function and limited side.